Bristol-Myers Squibb Company
Patents, Design & Utilities
Last updated:
List of all Bristol-Myers Squibb Company patents 772 in total
| Status | Patent |
|---|---|
Grant | Utility: Glypican-3-binding fibronectin based scaffold molecules Filling date: 6 Sep 2025 Issue date: 10 Mar 2020 |
Application | Utility: ANTIBODIES TO CD40 WITH ENHANCED AGONIST ACTIVITY Filling date: 6 Sep 2025 Issue date: 5 Mar 2020 |
Application | Utility: AMIDE-SUBSTITUTED HETEROCYCLIC COMPOUNDS USEFUL AS MODULATORS OF IL-12, IL-23 AND/OR IFN ALPHA RESPONSES Filling date: 6 Sep 2025 Issue date: 5 Mar 2020 |
Application | Utility: METHODS OF TREATING EARLY RHEUMATOID ARTHRITIS Filling date: 6 Sep 2025 Issue date: 5 Mar 2020 |
Application | Utility: METHODS FOR TREATING COSTIMULATION BLOCKADE RESISTANT REJECTION Filling date: 6 Sep 2025 Issue date: 5 Mar 2020 |
Application | Utility: INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF THEIR USE Filling date: 6 Sep 2025 Issue date: 5 Mar 2020 |
Application | Utility: INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF THEIR USE Filling date: 6 Sep 2025 Issue date: 5 Mar 2020 |
Application | Utility: SELECTIVE NR2B ANTAGONISTS Filling date: 6 Sep 2025 Issue date: 5 Mar 2020 |
Grant | Utility: Cancer immunotherapy by disrupting PD-1/PD-L1 signaling Filling date: 6 Sep 2025 Issue date: 3 Mar 2020 |
Grant | Utility: Carbamoyloxymethyl triazole cyclohexyl acids as LPA antagonists Filling date: 6 Sep 2025 Issue date: 3 Mar 2020 |
Grant | Utility: Macrocyclic inhibitors of myeloperoxidase Filling date: 6 Sep 2025 Issue date: 3 Mar 2020 |
Application | Utility: STABILIZED FIBRONECTIN BASED SCAFFOLD MOLECULES Filling date: 6 Sep 2025 Issue date: 27 Feb 2020 |
Application | Utility: COMBINATION OF ANTI-LAG-3 ANTIBODIES AND ANTI-PD-1 ANTIBODIES TO TREAT TUMORS Filling date: 6 Sep 2025 Issue date: 27 Feb 2020 |
Application | Utility: THIENOPYRIDINES AND BENZOTHIOPHENES USEFUL AS IRAK4 INHIBITORS Filling date: 6 Sep 2025 Issue date: 27 Feb 2020 |
Application | Utility: A SUPRAMOLECULAR HIGH AFFINITY PROTEIN-BINDING SYSTEM FOR PURIFICATION OF BIOMACROMOLECULES Filling date: 6 Sep 2025 Issue date: 27 Feb 2020 |
Grant | Utility: Substituted benzofuran compounds for the treatment of hepatitis C Filling date: 6 Sep 2025 Issue date: 25 Feb 2020 |
Application | Utility: PYRIMIDINONES AS FACTOR XIA INHIBITORS Filling date: 6 Sep 2025 Issue date: 20 Feb 2020 |
Grant | Utility: Triazolones and tetrazolones as inhibitors of ROCK Filling date: 6 Sep 2025 Issue date: 18 Feb 2020 |
Application | Utility: TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTS HAVING A PYRIDINE OR PYRAZINE MOIETY, CONJUGATES THEREOF, AND METHODS AND USES THEREFOR Filling date: 6 Sep 2025 Issue date: 13 Feb 2020 |
Application | Utility: TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTS HAVING A HETEROBIARYL MOIETY, CONJUGATES THEREOF, AND METHODS AND USES THEREFOR Filling date: 6 Sep 2025 Issue date: 13 Feb 2020 |
Application | Utility: SERUM ALBUMIN-BINDING FIBRONECTIN TYPE III DOMAINS Filling date: 6 Sep 2025 Issue date: 13 Feb 2020 |
Application | Utility: ACYL SULFONAMIDE NAV1.7 INHIBITORS Filling date: 6 Sep 2025 Issue date: 13 Feb 2020 |
Grant | Utility: IP-10 antibodies and their uses Filling date: 6 Sep 2025 Issue date: 11 Feb 2020 |
Application | Utility: [1,2,4]TRIAZOLO[1,5-A]PYRIDINYL SUBSTITUTED INDOLE COMPOUNDS Filling date: 6 Sep 2025 Issue date: 6 Feb 2020 |
Application | Utility: 2H-PYRAZOLO[4,3-d]PYRIMIDINE COMPOUNDS AS TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTS AND METHODS AND USES THEREFOR Filling date: 6 Sep 2025 Issue date: 6 Feb 2020 |
Application | Utility: 1H-PYRAZOLO[4,3-d]PYRIMIDINE COMPOUNDS AS TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTS AND METHODS AND USES THEREFOR Filling date: 6 Sep 2025 Issue date: 6 Feb 2020 |
Application | Utility: METHODS OF TREATMENT USING IL-23p19 MONOCLONAL ANTIBODIES Filling date: 6 Sep 2025 Issue date: 6 Feb 2020 |
Grant | Utility: Acyl sulfonamide NaV1.7 inhibitors Filling date: 6 Sep 2025 Issue date: 4 Feb 2020 |
Grant | Utility: Prodrugs of imidazotriazine compounds as CK2 inhibitors Filling date: 6 Sep 2025 Issue date: 4 Feb 2020 |
Application | Utility: ANTI-ICOS AGONIST ANTIBODIES AND USES THEREOF Filling date: 6 Sep 2025 Issue date: 30 Jan 2020 |
Grant | Utility: 4-azaindole compounds Filling date: 6 Sep 2025 Issue date: 28 Jan 2020 |
Grant | Utility: Heteroaryl substituted pyridyl compounds useful as kinase modulators Filling date: 6 Sep 2025 Issue date: 28 Jan 2020 |
Grant | Utility: Inhibitors of indoleamine 2,3-dioxygenase and methods of their use Filling date: 6 Sep 2025 Issue date: 28 Jan 2020 |
Grant | Utility: Biaryl kinase inhibitors Filling date: 6 Sep 2025 Issue date: 28 Jan 2020 |
Grant | Utility: Nucleic acids encoding antibody polypeptides that antagonize CD40 Filling date: 6 Sep 2025 Issue date: 28 Jan 2020 |
Grant | Utility: Method of treating cancer using immune checkpoint inhibitor Filling date: 6 Sep 2025 Issue date: 28 Jan 2020 |
Application | Utility: TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTS HAVING A BENZOTRIAZOLE MOIETY, CONJUGATES THEREOF, AND METHODS AND USES THEREFOR Filling date: 6 Sep 2025 Issue date: 23 Jan 2020 |
Application | Utility: ROR GAMMA MODULATORS Filling date: 6 Sep 2025 Issue date: 23 Jan 2020 |
Grant | Utility: Tetrazolone-substituted dihydropyridinone MGAT2 inhibitors Filling date: 6 Sep 2025 Issue date: 21 Jan 2020 |
Grant | Utility: Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions Filling date: 6 Sep 2025 Issue date: 21 Jan 2020 |
Application | Utility: TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTS HAVING A TRICYCLIC MOIETY, CONJUGATES THEREOF, AND METHODS AND USES THEREFOR Filling date: 6 Sep 2025 Issue date: 16 Jan 2020 |
Application | Utility: CARBOHYDRATE CONTENT OF CTLA4 MOLECULES Filling date: 6 Sep 2025 Issue date: 16 Jan 2020 |
Grant | Utility: Antibodies against TIM3 and uses thereof Filling date: 6 Sep 2025 Issue date: 14 Jan 2020 |
Application | Utility: TREATMENT OF PD-L1-POSITIVE MELANOMA USING AN ANTI-PD-1 ANTIBODY Filling date: 6 Sep 2025 Issue date: 9 Jan 2020 |
Application | Utility: ANTIBODIES THAT BIND NOVEL PCSK9 VARIANTS Filling date: 6 Sep 2025 Issue date: 9 Jan 2020 |
Grant | Utility: Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFN alpha responses Filling date: 6 Sep 2025 Issue date: 7 Jan 2020 |
Application | Utility: TREATMENT OF C1013G/CXCR4-ASSOCIATED WALDENSTROM'S MACROGLOBULINEMIA WITH AN ANTI-CXCR4 ANTIBODY Filling date: 6 Sep 2025 Issue date: 2 Jan 2020 |
Grant | Utility: Cyclic dinucleotides as anticancer agents Filling date: 6 Sep 2025 Issue date: 31 Dec 2019 |
Grant | Utility: Aryl substituted bicycle heteroaryl compounds Filling date: 6 Sep 2025 Issue date: 31 Dec 2019 |
Application | Utility: TREATMENT OF LUNG CANCER USING AN ANTI-FUCOSYL-GM1 ANTIBODY Filling date: 6 Sep 2025 Issue date: 26 Dec 2019 |
Showing 600 to 650 of 772 patents.